TrialHaematologica2025

Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial.

Richard F Schlenk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.